Select
the Abstracts by Number
Click
to
view the poster
232 Evaluation
of OraQuick HIV-1/2 Rapid Test and a Rapid/ Simple Test Algorithm in a High-
Risk/High-Prevalence Population in Bangkok, Thailand.
233 HAART
Reduces the Sensitivity of OraQuick HIV1/2, a Developmental Rapid Test Directed
Against a gp41 Peptide for HIV Diagnosis Using Oral Fluids or Serum.
234
Routinely
Recommending HIV Testing at a Large Urgent Care Center (UCC): Assessing an "Opt-Out"
Strategy with Standard Versus Rapid HIV Testing.
235
Failure
of Serologic Assays for Diagnosis of Hepatitis B and C Virus Infections in Patients
with Advanced HIV.
236 Rates
of False-Positive Results on Quantitative HIV RNA Assays.
237
A
Single Rapid Real- Time Monitored Isothermal RNA Amplification Assay for Quantification
of HIV-1 Isolates from Groups M, N, and O.
238 Clinical
Utility of a Quantitative Real-Time LightCycler PCR Assay forPneumocystis carinii.
239
NucliSens
EasyQ HIV-1: A Novel Viral Load Assay Based on Real-Time NASBA.
240
Comparative
Performance of Three Viral Load Assays on HIV-1 Viral Isolates Representing
Group M Subtypes A G and Group O.
241
Are
Measurements of Genital HIV-1 Viral Load in Women Reproducible?
242
Reliability
and Correlations of Repeated Viral Load Measures in Plasma and Gut Mucosa (GALT)
To Determine Baseline Characteristics in Clinical Trials.
243
Real-Time
HIV-1 PCR for the Diagnosis of Infection in Newborns of African Mothers.
244
Advantage
of Combined HIV Antibody and p24 Antigen Assays to 3rd-Generation HIV Assays
in the Diagnosis of HIV Infection.
245
Combined
HIV Antigen and Antibody Assay on a Fully Automated Chemiluminescence Analyzer
To Shorten the Seroconversion Window.
246
HIV-1
Surveillance in Vietnam: Correlation between V3 Peptide-Based Serotyping and
Sequence-Based Genotyping.
247 Feasibility
of a Subtype- Specific Hybridization Assay forenvGenotyping of Subtypes A through
G Including Discrimination of Recombinant Forms CRF01-AE and CRF02-AG.
248
Comparison
of Capillary Electrophoresis Sequencing with the New CEQ 2000 System (Beckman
Coulter Inc.) to Conventional Gel-Based Systems for HIV-1 Drug Resistance Analysis.
249
Validation
of the Ultrasensitive HIV-1 Genotyping Assay.
250 Performance
of the Applied Biosystems ViroSeq HIV- 1 Genotyping System for Analysis of Pediatric
Plasma Samples.
251 Worldwide
Evaluation of Genotypic Resistance Analysis Using Clinical HIV-I Isolates with
Complex Drug Resistance Profiles.
252
A Quality Control Trial for HIV-1 Drug Resistance Testing Using Clinical Samples.
253 HIV
Drug Resistance in the Texas Department of Criminal Justice.
254
Determination
of a Clinically Relevant Phenotypic Resistance "Cutoff" for Abacavir
Using the PhenoSense Assay.
255 A
Rapid, Automated, Inexpensive Assay for Point Mutations in HIV-1 pol Associated
with Resistance to Antiretrovirals.
256
Detection
and Quantification of Minor HIV-1 Populations with Multiple Drug Resistance-Associated
Mutations in Reverse Transcriptase by an Oligonucleotide Ligation Assay.